PMC:7696151 / 18419-18554 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"496","span":{"begin":40,"end":43},"obj":"Chemical"}],"attributes":[{"id":"A496","pred":"tao:has_database_id","subj":"496","obj":"MESH:D006886"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"pro-inflammatory mediators [25]. Hence, HCQ can be considered a promising drug able to maintain a low baseline level of immune activati"}